← Leaderboards
Andrew John Rech
University Of Pennsylvania
$812,500
Attributed
$812,500
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $406.3K · FY2024–25$500K$375K$250K$125K$0
'24
'25
Funding mix
By agency
NIH$812,500 · 1
By mechanism
DP5$812,500 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Mitchell D Schnall$128,628,301
- David A Mankoff$17,196,499
- Gregory L Beatty$6,306,069
- David Tuveson$22,023,736
- Terence P Gade$7,764,615
Others in their field
Other Rising Stars on “Antigen Targeting”
- Jason Dickens · Duke University$12,259,409
- Suma Babu · Massachusetts General Hospital$9,673,541
- Sabrina Paganoni · Massachusetts General Hospital$9,673,541
- Gregory Sorenson · University Of Maryland Baltimore County$9,161,697
- Li Liang · University Of California-Irvine$7,511,446
- Kai Xu · Ohio State University$4,891,156
Research focus
Antigen TargetingAreaBackBiobankBioinformaticsBiologicalBiological ModelsBiologyBlood TreatmentBoard CertificationCancer Infiltrating T CellsCareerCareer DevelopmentCar T Cell TherapyCell PhysiologyCellsCell SecretionCellular BiologyCharacteristicsChimeric Antigen ReceptorChimeric Antigen Receptor T CellsClinical TrialsCytokineAndrogen Receptor
Grant awards (2)
Response and resistance to chimeric antigen receptor T cell therapy in human solid tumors using spatial multi-omics$406,250
DP5 · FY2025 · OD · contact PI
Response and resistance to chimeric antigen receptor T cell therapy in human solid tumors using spatial multi-omics$406,250
DP5 · FY2024 · OD · contact PI